Hypoglycemia associated with the production of insulin-like growth factor II in adrenocortical carcinoma

Internal Medicine

Volumn 40, Issue 8, 2001, Pages 759-763

  Eguchi, Takako ^a,c   Tokuyama, Atsushi ^a   Tanaka, Yuri ^a   Takahashi, Yasunori ^a   Kawahara, Gen ^a   Aiba, Motohiko ^b   Inishi, Yoji ^a   Minowa, Hisashi ^a  

^a Omori Red Cross Hospital   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Kanagawa Prefectural Ashigara kami Hospital   (Japan)

Author keywords

Big insulin like growth factor II; Insulin like growth factor II insulin like growth factor I ratio; Non islet cell tumor hypoglycemia (NICTH)

Indexed keywords

SOMATOMEDIN B;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; AGED; ARTICLE; BLOOD; CASE REPORT; FEMALE; HUMAN; HYPOGLYCEMIA; PATHOLOGY; RADIOIMMUNOASSAY; SECRETION;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; AGED; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR II; RADIOIMMUNOASSAY;

EID: 0035432206     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.759     Document Type: Article

References (26)

1. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663, 1982.
2. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 8: 163-169, 1984.
3. Zapf J. Role of insulin-like growth factor II and IGF binding proteins in extrapancreatic tumor hypoglycemia. Horm Res 42: 20-26, 1994.
4. Wasada T, Hizuka N, Yamamoto M, et al. An insulin-like growth factor II producing histiocytoma associated with hypoglycemia. Metabolism 41: 310-316, 1992.
5. Aiba M, Hizuka N. Immunohistochemical studies of 15 cases with non-islet cell tumor hypoglycemia (NICTH). Clinical Endocrinology 46 (Suppl): 145-155, 1998 (in Japanese).
6. Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Inter Med 44: 700-710, 1929.
7. Kahn CR. The riddle of tumor hypoglycemia revisited. Clin Endocrinol Metab 9: 335-360, 1980.
8. Yoshikawa K, Wakasa H. Hypoglycemia by adrenocortical carcinoma with Cushing's syndrome. Tohoku J exp Med 132: 49-60, 1980.
9. KamioT, Shigematsu K, Kawai K, Tsuchiyama H. Immunoreactivity and receptor expression of insulinlike growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases. Am J Pathol 138: 83-91, 1991.
10. Unger RH. The riddle of tumor hypoglycemia. Am J Med 40: 325-330, 1966.
11. Silverstein MN, Wakim KG, Bahn RC. Tryptophan metabolites in hypoglycemia associated with neoplasia. Cancer 19: 2024-2028, 1966.
12. Silverstein MN. Tumor hypoglycemia. Cancer 23: 142-144, 1969.
13. Rustin MH, Bowcock SJ, Coomes EN. Adrenocortical carcinoma with tumor-induced hypoglycemia. J R Soc Med 76: 74-75, 1983.
14. Scholz DA, Horton ES, Lebovitz HE, Ferris DO. Spontaneous hypoglycemia associated with an adrenocortical carcinoma. J Clin Endocrinol Metab 27: 991-996, 1967.
15. Megyesi K, Kahn CR, Roth J, Gorden P. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components. J Clin Endocrinol Metab 41: 475-484, 1975.
16. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319: 1434-1440, 1988.
17. Zapf J, Futo E, Peter M, Froesch ER. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584, 1992.
18. Enjoh T, Hizuka N, Perdue JF, et al. Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis. J Clin Endicrinol Metab 77: 510-517, 1993.
19. Ilvesmaki V, Kahri AI, Miettinen PJ, Voutilainen R. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: High IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab 77: 852-858, 1993.
20. Gicquel C, Bertagna X, Schneid H, et al. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 78: 1444-1453, 1994.
21. Liu J, Kahri AI, Heikkila P, Ilvesmaki V, Voutilainen R. H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 80: 492-496, 1995.
22. Ilvesmaki V, Liu J, Heikkila P, Kahri AI, Voutilainen R. Expression of insulin-like gorwth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas. Horm Metab Res 30: 619-623, 1998.
23. Schneid H, Seurin D, Noguiez P, Le Bouc Y. Abnormalities of insulin-like growth factor (IGF-I and IGF-II) genes in human tumor tissue. Growth Regul 2: 45-54, 1992.
24. Liu J, Kahri AI, Heikkila P, Blum WF, Voutilainen R. Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human pheochromocytoma cells. J Endocrinol 142: 29-35, 1994.
25. Pavelic K, Cabrijan T, Hrascan R, et al. Molecular pathology of hemangiopericytomas accompanied by severe hypoglycemia: oncogenes, tumor-suppressor genes and the insulin-like growth factor family. J Cancer Res Clin Oncol 124: 307-314, 1998.
26. Hizuka N, Fukuda I, Takano K, Okubo Y, Asakawa-Yasumoto K, Demura H. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia. Endocr J 45 Suppl: S61-S65, 1998.